My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Scilex Holding Company - Common Stock (NQ:SCLX)

17.64 -3.04 (-14.70%)
Streaming Delayed Price Updated: 11:07 AM EDT, Oct 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Scilex Holding Company - Common Stock

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Closes Initial Tranche of $150 Million Bitcoin Investment from Scilex Holding
Via Investor Brand Network
Topics Artificial Intelligence
TechMediaBreaks – Datavault AI Inc. (NASDAQ: DVLT) Closes Initial Tranche of $150 Million Bitcoin Investment from Scilex Holding
Via Investor Brand Network
Topics Artificial Intelligence
DefenseNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Surges as Market Rethinks Its Story
Via Investor Brand Network
Topics Artificial Intelligence
TechMediaBreaks – Datavault AI Inc. (NASDAQ: DVLT) Secures $150 Million Strategic Investment from Scilex Holding Company
Via Investor Brand Network
Topics Artificial Intelligence
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination
From Denali Capital Acquisition Corp.
Via GlobeNewswire
MarketBeat: Week in Review 01/09-01/13
Markets are looking for direction in early trading before a holiday weekend. Here are some of the popular stories MarketBeat analysts were covering this week. 
Via MarketBeat
Topics Economy
Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
Sorrento Therapeutics is on the move following preliminary results from its subsidiary Scilex. Scilex is making money with the company's 1st product to market 
Via MarketBeat
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.